Lynch syndrome is the most common genetic predisposition to cancer, yet often goes undiagnosed.

Lynch syndrome is the most common genetic predisposition to cancer, yet often goes undiagnosed.
Image: Intellect (generated)

In short: Lynch syndrome, or HNPCC, is an inherited condition that significantly elevates the risk of colorectal and endometrial cancers. Caused by mutations in DNA mismatch repair genes, it affects roughly one in 500 people. While often overlooked, identifying this syndrome is critical for life-saving, early-stage cancer detection and surveillance.

Lynch syndrome, historically termed hereditary nonpolyposis colorectal cancer (HNPCC), is an autosomal dominant genetic disorder. It arises from mutations in one of four primary DNA mismatch repair (MMR) genes—MLH1, MSH2, MSH6, and PMS2—which are responsible for correcting errors that occur during DNA replication. When these genes fail, cells accumulate mutations at an accelerated rate, leading to microsatellite instability and a substantially increased risk of developing various malignancies, most notably in the colon and endometrium.

The clinical identification of the syndrome relies on specific criteria, such as the Amsterdam Criteria and the Bethesda Guidelines, which track familial cancer history and age of onset. Patients with Lynch syndrome frequently develop colorectal cancer before age 50, with an average onset around 45 years. Because the syndrome is highly penetrant, it poses unique challenges for clinical evaluation, requiring specialized screening measures like annual colonoscopies. Despite its prevalence, many cases remain unrecognized, as some families meeting clinical criteria show no identifiable MMR defect, suggesting that other, yet-to-be-discovered genetic factors may contribute to the disease.

The history of the condition is tied to American oncologist Henry T. Lynch, who characterized the syndrome in 1966, initially describing it as 'cancer family syndrome.' While the terms HNPCC and Lynch syndrome are often used synonymously in clinical practice, the latter is increasingly preferred to describe cases with a confirmed MMR defect. Ongoing research into the genetic basis of these tumors has significantly improved patient care, shifting the focus from reactive treatment to proactive, risk-adapted surveillance strategies that can catch cancers at earlier, more treatable stages.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-hereditary-nonpolyposis-colorectal-cancer.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…